Mainstream

Earnings Snapshot: Merck FY25 sales outlook falls short of estimates even as Q4 beats

Earnings Snapshot: Merck FY25 sales outlook falls short of estimates even as Q4 beats

Post ContentmrkRead More

You might also be interested in reading Biggest stock movers Wednesday: VRNA, AEHR, EVTL, RXST and more.

February 4, 2025
In Mainstream